We make knowledge usable, for healthcare professionals, clinical laboratories, and researchers
To that end, we:
Focus on patients
Our work aims to improve the quality and speed of treatment and care options.
Deliver usable results
A transparent, intuitive, and informative user experience is at the core of our solutions.
Promote innovation
Our solutions evolve to meet current healthcare needs and recommendations.
Build on diversity
Our teams tackle challenges with diverse ideas, strengths, and backgrounds.
Our people:
our greatest asset
Partnering with Molecular Health means more than using cutting-edge solutions like MH Guide for clinical decision support and Dataome Technology for AI-guided drug development. Our talented team of experts is like an extension of your efforts to grow and use knowledge.
Our highly skilled subject matter experts ensure that our solutions always provide clean, relevant, high-quality data and top analytical performance to guide personalized therapy decisions and overcome some of the biggest hurdles in drug development. Our analytics experts engineer the analysis functions of MH Guide and the dedicated data-driven analyses for AI Pharma Solutions. Their analytical strategies are documented and traceable, so customers can rely on our solutions and services to tackle challenges.
Read about our work:
Our database experts work behind the scenes to vet, organize, structure, and connect the massive datasets that are wrangled, standardized, and integrated from numerous sources into Dataome. Concurrently, our professional biomedical data curators keep a finger on the state of biomedical knowledge – from real-world data, molecular findings, and genomic insights to recommendations from authorities and regulatory drug approvals. Their work ensures that our solutions remain highly reliable, current, relevant, and useful to those who use them. In fact, our curators highlight high-impact publications, which we share with customers in our newsletter.
Finally, our Customer Success Team includes application specialists who ensure that our partners are able to use MH Guide to its fullest potential, providing guidance and support as needed. So, when you choose Molecular Health, you’re getting powerful tools and a team of experts who work to grant you cutting-edge, evidence-based insights that underscore meaningful decisions in healthcare and drug development.
Do you want to join our young and engaged team of experts?
Our management team
Friedrich von Bohlen und Halbach, PhD
Chief Executive Officer
Friedrich von Bohlen und Halbach, PhD
Chief Executive Officer
Chief Executive Officer
Friedrich von Bohlen und Halbach is a co-founder of Molecular Health. He has over 25 years of entrepreneurial experience in the industry and serves as chairman or board member of several national and international biotech companies and organizations. He holds a diploma in biochemistry from the University Zurich and a PhD in neurobiology from the Swiss Federal Institute of Technology, Zurich.
Stephan Brock, PhD
Chief Technology Officer and General Manager
Stephan Brock, PhD
Chief Technology Officer and General Manager
Chief Technology Officer and General Manager
Stephan Brock is co-founder of Molecular Health. He has extensive experience in bioinformatics, data integration analytics, artificial intelligence, text-data mining, and content management for the pharmaceutical industry. He has led large-scale projects developing bioinformatics solutions supporting the pharma R&D value chain and IT infrastructure for integrative clinical trial data management at cancer centers. He holds a PhD in biochemistry from the University of Bayreuth.
Burkard Piper
Member of the Executive Team
Burkard Piper
Member of the Executive Team
Member of the Executive Team
Jochen Theis, MD FFPM
Acting Chief Medical Officer
Jochen Theis, MD FFPM
Acting Chief Medical Officer
Acting Chief Medical Officer
Jochen Theis is a pharmaceutical executive and consultant with 25 years of experience in drug discovery and development, precision medicine, and translational science. He brings insights from in-depth practical experience in the development of therapeutics and diagnostics at major pharmaceutical manufacturers and successful biotechs to guide company innovation strategy and align R&D collaborations.
Matthias Kopf, PhD
SVP, Head of Business Unit Clinical Decision Support
Matthias Kopf, PhD
SVP, Head of Business Unit Clinical Decision Support
SVP, Head of Business Unit Clinical Decision Support
took over leadership of the Clinical Decision Support Business Unit in 2023 after serving as Head of Product Management for five years. In his role, he oversees product management, customer success, medical affairs, marketing, and sales activities around MH Guide. He has a background in molecular biology and bioinformatics, having obtained his PhD in bioinformatics from the University of Freiburg (Germany) in 2015.
Niels Bojunga, PhD
SVP of Quality Management
Niels Bojunga, PhD
SVP of Quality Management
SVP of Quality Management
Niels Bojunga is a microbiologist by training with over 20 years of professional experience in the area of software quality. As Head of Quality Management at Molecular Health, he oversees the company’s quality management system and quality assurance and guides regulatory compliance and certifications. He is the Quality Management Representative and Person Responsible for Regulatory Compliance (PRRC) of Molecular Health.
Josef Hermanns, PhD
SVP, Head of Project Management
Josef Hermanns, PhD
SVP, Head of Project Management
SVP, Head of Project Management
Josef Hermanns has over two decades of experience in strategic growth planning for IT, project controlling, and bioinformatics development. At Molecular Health, he coordinates central and AI Pharma Service projects, manages resources and licenses in R&D, and oversees data curation and content management for Dataome. He has a PhD from the Ruhr University Bochum (Germany).
Thorsten Vogt
Head of Human Resources
Thorsten Vogt
Head of Human Resources
Head of Human Resources
Thorsten Vogt has led Human Resources at Molecular Health since 2015. During that time, he guided the strategic expansion of all company sites and fostered the integration of employees from over 30 different countries. He oversees all personnel affairs, leveraging expertise from over two decades of managerial experience at international software and industrial corporations.
Your contacts
Stephan Hettich
SVP, Business Development MH
Stephan Hettich
SVP, Business Development MH
SVP, Business Development MH
Questions and requests regarding strategic investments, or the establishment and development of business partnerships and collaborations around MH Guide can be discussed with Stephan.
Reach out to Stephan
Marc-Alexander Rauschendorf, PhD
Head of Medical Affairs & Marketing CDS
Marc-Alexander Rauschendorf, PhD
Head of Medical Affairs & Marketing CDS
Head of Medical Affairs & Marketing CDS
Reach out to Marc with questions about clinical trials, medical collaborations, tumor board support and KOL management. He also oversees attendance at conferences, outreach, PR, and publications.
Reach out to Marc
Lenka Kyjacova, PhD
Head of Customer Success
Lenka Kyjacova, PhD
Head of Customer Success
Head of Customer Success
Interested in MH Guide? Contact Lenka to start your MH Guide journey. She can provide a demo, walk you through a tailored on-boarding, and train you on product features. Customers can send support requests or questions about MH Guide, customized workflows, or newly released features to Lenka and local teams.
Reach out to Lenka
Melanie Baumhögger
Head of Finance
Melanie Baumhögger
Head of Finance
Head of Finance
Melanie handles any finance-related questions, from invoicing and purchase orders to accounts payable, fiscal statements, value added tax, and accounting.
Reach out to Melanie
Biljana Blagojevic, PhD
Scientific Process & Project Manager AI Pharma Solutions
Biljana Blagojevic, PhD
Scientific Process & Project Manager AI Pharma Solutions
Scientific Process & Project Manager AI Pharma Solutions
Whether you’re seeking a first contact, have specific questions about a possible collaboration, or want quick support within your ongoing AI Pharma Service project, get in touch with Biljana.
Reach out to BiljanaOur Board of Directors
Prof. Christof Hettich, PhD
Chairman of the Board of Directors
Prof. Christof Hettich, PhD
Chairman of the Board of Directors
is the CEO of SRH Holding, a leading provider of education and health services in Germany. He is also a senior partner at Rittershaus Rechtsanwälte, a law firm focusing on future-oriented industries, and co-founder of dievini Hopp BioTech Holding & Co. KG, the largest German investment company for LifeSciences, Healthcare and Health IT. He holds a doctorate in law and has extensive experience in corporate governance and financing.
Mathias Hothum, PhD
Member of the Board of Directors
Mathias Hothum, PhD
Member of the Board of Directors
is the managing director of dievini Hopp Biotech holding GmbH & Co. KG. He is currently also the founder and owner of HMM Consulting and the managing director of MSL Investments, DH Holding Verwaltungs, and MH-LT-Investments GmbH. He serves as Chairman of the Board of Joimax GmbH and Geuder AG, and as board member of Apogenix AG, CureVac NV, Heidelberg Pharma AG, and Novaliq GmbH. He studied business administration at the University of Mannheim and holds a PhD from the University of Magdeburg, Germany.
Alexander O. Schuth, PhD
Member of the Board of Directors
Alexander O. Schuth, PhD
Member of the Board of Directors
is co-founder and Chief Operating and Financial Officer of Denali Therapeutics, a biotechnology company focused on developing therapies for neurodegenerative diseases. He has extensive experience in corporate development, portfolio management, and finance. Before joining Denali, he worked at Genentech and the investment banking group at Merrill Lynch. He holds an M.D. from Humboldt University in Berlin and an M.B.A. from the Wharton School of the University of Pennsylvania.
Invest in precision medicine
Molecular Health is privately funded by dievini Hopp Biotech holding GmbH & Co. KG, which invests in innovative precision medicine companies with a focus on oncology, neurology, infectious diseases, cell therapy, and improved drug formulation. They support companies in their global development and marketing, with a geographic focus on Germany and Europe.
Do you have additional questions about our solutions and services? We want to hear from you!